PEP (post-exposure prophylaxis) is highly effective at preventing HIV when taken correctly. In one of the largest cohort studies, involving over 2,700 people who received PEP after a potential HIV exposure, only one case of HIV infection could be attributed to actual PEP failure, a rate of 0.04%. The other seroconversions in the study were linked to continued high-risk behavior after treatment, not to the medication failing.
What the Evidence Shows
No randomized, placebo-controlled trial has ever tested PEP against a sugar pill in humans, for obvious ethical reasons. You can’t give someone a placebo after a real HIV exposure. Instead, PEP’s effectiveness comes from animal studies, observational data, and large cohort analyses. The evidence consistently supports the same conclusion: starting PEP soon after exposure and completing the full 28-day course dramatically reduces the chance of acquiring HIV.
The most cited figure is that PEP reduces HIV transmission risk by roughly 80% or more. But the real-world data suggests the protection may be even higher when people take the medication as prescribed. In a major North American cohort study published in PLOS ONE, 2,731 patients received PEP after potential exposures. Ten of those patients later tested positive for HIV (0.37%), but nine of those cases involved people who continued engaging in high-risk behavior during or after treatment. Only one case represented a true medication failure.
Timing Is Critical
PEP must be started within 72 hours of a potential HIV exposure, and sooner is better. Every hour matters. The medications work by blocking HIV from establishing itself in your cells before the virus can replicate and spread throughout your body. The longer you wait, the more opportunity the virus has to gain a foothold.
Starting within the first 24 hours gives you the best chance of success. By 72 hours, the window is closing. After 72 hours, PEP is generally not prescribed because the likelihood of it working drops significantly. If you think you’ve been exposed, getting to an emergency room or sexual health clinic the same day is the single most important thing you can do.
The 28-Day Commitment
PEP is a 28-day course of antiretroviral medications, the same class of drugs used to treat HIV. The current preferred regimens combine two or three antiretrovirals into one or two pills taken daily. Completing the full course is essential. In the large cohort study, 69% of patients finished their entire prescribed treatment. Another 16% were lost to follow-up, meaning they stopped coming to appointments and may or may not have finished their pills. Only 4% formally discontinued treatment, and 2% missed more than five doses.
Adherence matters because the medications need to maintain consistent levels in your body to keep the virus from replicating. Missing occasional doses doesn’t automatically mean PEP will fail. Researchers in the cohort study defined “adherent” as missing no more than five doses over the month. Among the ten patients who seroconverted, nine had actually completed treatment and were considered compliant, but those cases were tied to new exposures rather than the medication not working.
Side Effects and Sticking With It
The most common reason people struggle to finish PEP is side effects. Nausea, fatigue, headaches, and diarrhea are the complaints that come up most often, particularly in the first week or two. For most people, these symptoms are mild and manageable. They tend to ease as your body adjusts to the medication. Newer drug regimens have fewer side effects than older ones, which has improved completion rates over time.
If side effects become difficult, your prescriber can sometimes switch you to a different combination rather than stopping treatment entirely. Pushing through mild discomfort for 28 days is worth it given what’s at stake.
Follow-Up Testing After PEP
Finishing the pills isn’t the final step. You’ll need HIV testing at 30 days and again at 90 days after completing treatment. The 30-day test catches early infections, while the 90-day test confirms your final status. Some testing methods can detect HIV sooner than others, but the three-month mark is when you can be confident in a negative result. During this waiting period, using condoms and avoiding other high-risk exposures protects both you and any partners.
How PEP Compares to PrEP
PEP is the emergency option, taken after a specific exposure. PrEP (pre-exposure prophylaxis) is the ongoing preventive option, taken before exposure by people at elevated risk. PrEP, when taken consistently, prevents over 99% of HIV infections from sexual contact. If you find yourself needing PEP more than once, your provider will likely discuss transitioning to PrEP as a more sustainable strategy. PrEP eliminates the scramble to start medication within 72 hours because the protection is already in place.
Accessing PEP
In the United States, PEP is available through emergency rooms, urgent care clinics, sexual health clinics, and many primary care offices. Cost can be a barrier: without insurance, a 28-day course of antiretrovirals can run several hundred to over a thousand dollars depending on the specific regimen. However, most insurance plans and Medicaid cover PEP. Manufacturer assistance programs and state-funded programs also exist to help cover costs for uninsured patients. Many emergency rooms will start you on PEP and connect you with resources to cover the remaining days of medication.
The bottom line: PEP works extraordinarily well when you start it quickly and take every dose for the full 28 days. The true failure rate in real-world studies is vanishingly small. The biggest risks aren’t the medication failing but rather starting too late, not finishing the course, or having new exposures during or after treatment.